B

Brainsway Ltd
TASE:BWAY

Watchlist Manager
Brainsway Ltd
TASE:BWAY
Watchlist
Price: 1 808 ILS -2.53% Market Closed
Market Cap: 594m ILS
Have any thoughts about
Brainsway Ltd?
Write Note

Brainsway Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brainsway Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
Brainsway Ltd
TASE:BWAY
Capital Expenditures
-$2.4m
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
5%
Nano-X Imaging Ltd
NASDAQ:NNOX
Capital Expenditures
-$3.3m
CAGR 3-Years
38%
CAGR 5-Years
-116%
CAGR 10-Years
N/A
Inmode Ltd
NASDAQ:INMD
Capital Expenditures
-$440k
CAGR 3-Years
21%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Capital Expenditures
-$6.8m
CAGR 3-Years
-10%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Capital Expenditures
-$407k
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Capital Expenditures
-$4.1m
CAGR 3-Years
-240%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brainsway Ltd
Glance View

Market Cap
594m ILS
Industry
Health Care

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

BWAY Intrinsic Value
2 161.92 ILS
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is Brainsway Ltd's Capital Expenditures?
Capital Expenditures
-2.4m USD

Based on the financial report for Dec 31, 2023, Brainsway Ltd's Capital Expenditures amounts to -2.4m USD.

What is Brainsway Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
5%

The average annual Capital Expenditures growth rates for Brainsway Ltd have been 1% over the past three years , -4% over the past five years , and 5% over the past ten years .

Back to Top